Open Access
Issue
Vet. Res.
Volume 41, Number 5, September–October 2010
Number of page(s) 12
DOI https://doi.org/10.1051/vetres/2010026
Published online 29 April 2010
How to cite this article Vet. Res. (2010) 41:56
  • Blackburn E.H., Switching and signaling at the telomere, Cell (2001) 106:661–673. [CrossRef] [PubMed] [Google Scholar]
  • Calnek B.W., Marek’s disease – a model for herpesvirus oncology, Crit. Rev. Microbiol. (1986) 12:293–320. [CrossRef] [PubMed] [Google Scholar]
  • Calnek B.W., Pathogenesis of Marek’s disease virus infection, Curr. Top. Microbiol. Immunol. (2001) 255:25–55. [PubMed] [Google Scholar]
  • Davison A., Comments on the phylogenetics and evolution of herpesviruses and other large DNA viruses, Virus Res. (2002) 82:127–132. [CrossRef] [PubMed] [Google Scholar]
  • Davison A.J., Evolution of the herpesviruses, Vet. Microbiol. (2002) 86:69–88. [CrossRef] [PubMed] [Google Scholar]
  • Delany M.E., Krupkin A.B., Miller M.M., Organization of telomere sequences in birds: evidence for arrays of extreme length and for in vivo shortening, Cytogenet. Cell Genet. (2000) 90:139–145. [CrossRef] [PubMed] [Google Scholar]
  • Fragnet L., Blasco M.A., Klapper W., Rasschaert D., The RNA subunit of telomerase is encoded by Marek’s disease virus, J. Virol. (2003) 77:5985–5996. [CrossRef] [PubMed] [Google Scholar]
  • Fragnet L., Kut E., Rasschaert D., Comparative functional study of the viral telomerase RNA based on natural mutations, J. Biol. Chem. (2005) 280:23502–23515. [CrossRef] [PubMed] [Google Scholar]
  • Harley C.B., Futcher A.B., Greider C.W., Telomeres shorten during ageing of human fibroblasts, Nature (1990) 345:458–460. [CrossRef] [PubMed] [Google Scholar]
  • Harley C.B., Vaziri H., Counter C.M., Allsopp R.C., The telomere hypothesis of cellular aging, Exp. Gerontol. (1992) 27:375–382. [CrossRef] [PubMed] [Google Scholar]
  • Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., et al., Activation of telomerase in human lymphocytes and hematopoietic progenitor cells, J. Immunol. (1995) 155:3711–3715. [PubMed] [Google Scholar]
  • Jarosinski K.W., Osterrieder N., Nair V.K., Schat K.A., Attenuation of Marek’s disease virus by deletion of open reading frame RLORF4 but not RLORF5a, J. Virol. (2005) 79:11647–11659. [CrossRef] [PubMed] [Google Scholar]
  • Jarosinski K.W., Margulis N.G., Kamil J.P., Spatz S.J., Nair V.K., Osterrieder N., Horizontal transmission of Marek’s disease virus requires US2, the UL13 protein kinase, and gC, J. Virol. (2007) 81:10575–10587. [CrossRef] [PubMed] [Google Scholar]
  • Jones D., Lee L., Liu J.L., Kung H.J., Tillotson J.K., Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors, Proc. Natl. Acad. Sci. USA (1992) 89:4042–4046. [CrossRef] [Google Scholar]
  • Kamil J.P., Tischer B.K., Trapp S., Nair V.K., Osterrieder N., Kung H.J., vLIP, a viral lipase homologue, is a virulence factor of Marek’s disease virus, J. Virol. (2005) 79:6984–6996. [CrossRef] [PubMed] [Google Scholar]
  • Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al., Specific association of human telomerase activity with immortal cells and cancer, Science (1994) 266:2011–2015. [CrossRef] [PubMed] [Google Scholar]
  • Kingham B.F., Zelnik V., Kopacek J., Majerciak V., Ney E., Schmidt C.J., The genome of herpesvirus of turkeys: comparative analysis with Marek’s disease viruses, J. Gen. Virol. (2001) 82:1123–1135. [PubMed] [Google Scholar]
  • Levy A.M., Izumiya Y., Brunovskis P., Xia L., Parcells M.S., Reddy S.M., et al al., Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek’s disease virus-transformed T cells, J. Virol. (2003) 77:12841–12851. [CrossRef] [PubMed] [Google Scholar]
  • Levy A.M., Gilad O., Xia L., Izumiya Y., Choi J., Tsalenko A., et al., Marek’s disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses, Proc. Natl. Acad. Sci. USA (2005) 102:14831–14836. [CrossRef] [Google Scholar]
  • Lindsey J., McGill N.I., Lindsey L.A., Green D.K., Cooke H.J., In vivo loss of telomeric repeats with age in humans, Mutat. Res. (1991) 256:45–48. [PubMed] [Google Scholar]
  • Lupiani B., Lee L.F., Cui X., Gimeno I., Anderson A., Morgan R.W., et al., Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication, Proc. Natl. Acad. Sci. USA (2004) 101:11815–11820. [CrossRef] [Google Scholar]
  • Mergny J.L., Riou J.F., Mailliet P., Teulade-Fichou M.P., Gilson E., Natural and pharmacological regulation of telomerase, Nucleic Acids Res. (2002) 30:839–865. [CrossRef] [PubMed] [Google Scholar]
  • Nair V.K., Kung H.J., Marek’s disease virus oncogenicity: molecular mechanisms, in: Davison F., Nair V. (Eds.), Marek’s disease, an evolving problem, Elsevier Academic Press, London, 2004. [Google Scholar]
  • Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., Trapp S., Marek’s disease virus: from miasma to model, Nat. Rev. Microbiol. (2006) 4:283–294. [CrossRef] [PubMed] [Google Scholar]
  • Parcells M.S., Anderson A.S., Cantello J.L., Morgan R.W., Characterization of Marek’s disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames, J. Virol. (1994) 68:8239–8253. [PubMed] [Google Scholar]
  • Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V.K., Oncogenicity of virulent Marek’s disease virus cloned as bacterial artificial chromosomes, J. Virol. (2004) 78:13376–13380. [CrossRef] [PubMed] [Google Scholar]
  • Ross N., O’Sullivan G., Rothwell C., Smith G., Burgess S.C., Rennie M., et al., Marek’s disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek’s disease lymphomas, J. Gen. Virol. (1997) 78:2191–2198. [PubMed] [Google Scholar]
  • Rudolph J., Seyboldt C., Granzow H., Osterrieder N., The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M, J. Virol. (2002) 76:2952–2963. [CrossRef] [PubMed] [Google Scholar]
  • Schat K.A., Chen C.L., Calnek B.W., Char D., Transformation of T-lymphocyte subsets by Marek’s disease herpesvirus, J. Virol. (1991) 65:1408–1413. [PubMed] [Google Scholar]
  • Schumacher D., Tischer B.K., Fuchs W., Osterrieder N., Reconstitution of Marek’s disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant, J. Virol. (2000) 74:11088–11098. [CrossRef] [PubMed] [Google Scholar]
  • Shay J.W., Bacchetti S., A survey of telomerase activity in human cancer, Eur. J. Cancer (1997) 33:787–791. [CrossRef] [PubMed] [Google Scholar]
  • Shay J.W., Wright W.E., Telomerase: a target for cancer therapeutics, Cancer Cell. (2002) 2:257–265. [CrossRef] [PubMed] [Google Scholar]
  • Shkreli M., Dambrine G., Soubieux D., Kut E., Rasschaert D., Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek’s disease virus-induced lymphomagenesis, J. Virol. (2007) 81:4848–4857. [CrossRef] [PubMed] [Google Scholar]
  • Taylor H.A., Delany M.E., Ontogeny of telomerase in chicken: impact of downregulation on pre- and postnatal telomere length in vivo, Dev. Growth Differ. (2000) 42:613–621. [CrossRef] [PubMed] [Google Scholar]
  • Tischer B.K., von Einem J., Kaufer B., Osterrieder N., Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli, Biotechniques (2006) 40:191–197. [CrossRef] [PubMed] [Google Scholar]
  • Trapp S., Parcells M.S., Kamil J.P., Schumacher D., Tischer B.K., Kumar P.M., et al., A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis, J. Exp. Med. (2006) 203:1307–1317. [CrossRef] [PubMed] [Google Scholar]
  • Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., Kutish G.F., The genome of a very virulent Marek’s disease virus, J. Virol. (2000) 74:7980–7988. [CrossRef] [PubMed] [Google Scholar]
  • Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W., Telomerase activity in human germline and embryonic tissues and cells, Dev. Genet. (1996) 18:173–179. [CrossRef] [PubMed] [Google Scholar]
  • Yunis R., Jarosinski K.W., Schat K.A., Association between rate of viral genome replication and virulence of Marek’s disease herpesvirus strains, Virology (2004) 328:142–150. [CrossRef] [PubMed] [Google Scholar]
  • Zakian V.A., Telomeres: beginning to understand the end, Science (1995) 270:1601–1607. [CrossRef] [PubMed] [Google Scholar]